Jaguar Health (JAGX) Trading 15.4% Higher
Shares of Jaguar Health Inc (NASDAQ:JAGX) traded up 15.4% on Wednesday . The company traded as high as $0.33 and last traded at $0.28. 21,696,699 shares were traded during mid-day trading, an increase of 363% from the average session volume of 4,682,525 shares. The stock had previously closed at $0.24.
Separately, ValuEngine lowered shares of Jaguar Health from a “buy” rating to a “hold” rating in a research report on Thursday, January 24th.
The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.31 and a current ratio of 0.46.
Jaguar Health Company Profile (NASDAQ:JAGX)
Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
Featured Article: What is the LIBOR?
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.